AstraZeneca Covid booster shot effective against severe disease, UK study finds

The researchers from the UK Health Security Agency, London, estimated vaccine effectiveness by analysing data on all adults aged 18 years and above who were vaccinated with the AstraZeneca primary vaccine and either the same or the Pfizer booster vaccine. A total of 43,171 individuals received an AstraZeneca booster dose, while 13,038,908 individuals received a Pfizer booster dose.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news